Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101508672B details a resin-catalyzed esterification method for 1,4-dihydropyridines, offering high purity and scalable production for cardiovascular drug manufacturers.
Explore the novel synthesis of taspinine biphenyl derivatives with antitumor activity. Discover cost-effective manufacturing routes and reliable supply chain solutions for API intermediates.
Patent CN110577482B reveals a novel 2-step one-pot synthesis for Amisulpride. Discover cost-effective manufacturing, high purity yields, and reliable supply chain solutions.
Novel non-aqueous synthetic method for 2-thiophene ethylamine ensures high purity and green manufacturing for cardiovascular drug intermediates supply chain.
Novel CuBr-catalyzed alkenylation method offers high yield and low cost for trans-styryl benzofuranone production, ensuring supply chain stability.
Advanced purification method for Tedizolid Phosphate using absolute ethanol. Eliminates high-boiling solvents for superior purity and cost-effective API manufacturing.
Improved synthesis of Bardoxolone lactone derivatives using oleanolic acid. Reduces steps, eliminates heavy metals, ensures high purity for pharmaceutical supply chains.
Patent CN102030798B reveals a novel triflate salt purification method for Abiraterone Acetate. Achieves >97% purity, eliminates chromatography, and ensures scalable supply.
Patent CN107540598B reveals a low-cost, two-step route for N-difluoromethylthio phthalimide, enabling scalable SCF2H introduction for drug discovery.
Patent CN114456207B reveals a green visible light nickel catalyzed method for chiral beta-aryl ketones, offering cost reduction and scalable supply for pharmaceutical intermediates.
Patent CN116143673B reveals a novel heterogeneous catalyst method for diphenyl sulfide. Achieves high purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN102627594A details a novel sulfuric acid-catalyzed route for aziridines. Offers >99% purity, >85% yield, and scalable cost reduction for pharmaceutical manufacturing.
Patent CN104744380B reveals green ionic liquid catalysis for quinazolinones offering significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing.
Novel KMnO4 oxidation route for Roflumilast reduces hazardous waste. Enables cost effective API manufacturing with high purity standards.
Patent CN110590819A introduces a chitosan-copper catalyzed method for organoboron compounds. Offers cost reduction in pharmaceutical intermediates manufacturing with water-based green chemistry.
Patent CN111675690A details a metal-free benzothiophene synthesis using DTPB. This method offers significant cost reduction and simplified purification for pharmaceutical manufacturing.
Patent CN105037381A enables green synthesis using ionic liquids. Reduces waste and improves supply chain reliability for pharmaceutical intermediate manufacturing globally.
Advanced patent-based synthesis of Cabazitaxel intermediates offering high yield and regioselectivity. Reliable supply chain solutions for complex anticancer drug manufacturing.
Patent CN115894365B reveals a scalable route for morphine intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Patent CN110054597B reveals a metal-free route for thiazolidin-4-one derivatives, offering significant cost reduction and high purity for pharmaceutical intermediate manufacturing.